Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.1 EUR | -1.28% |
|
-4.13% | -19.44% |
28/06 | Would you like some more inflation? | ![]() |
28/06 | Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GENMAB A/S | Bio Therapeutic Drugs | -0.85% | -4.13% | -19.44% | -33.33% | - | 15.91B | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- GMAB Stock
- GE91 Stock
- Charts Genmab A/S
- Comparison Chart